Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-linked Inhibitor of Apoptosis Protein (XIAP) is a key regulator of apoptosis, directly inhibiting caspases-3, -7, and -9. It functions as an E3 ubiquitin ligase, influencing the stability of various proteins. XIAP is implicated in immune regulation, cell migration, and cancer, where its overexpression contributes to chemoresistance. It is a therapeutic target for sensitizing tumors to chemotherapy, but its broad expression raises concerns about potential side effects.
Direct inhibition of caspases-3, -7, and -9; Ubiquitination and proteasomal degradation of target proteins
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-linked Inhibitor of Apoptosis Protein (XIAP).